Medical Developments International Limited

CHIA:MVP Stock Report

Market Cap: AU$46.8m

Medical Developments International Future Growth

Future criteria checks 4/6

Medical Developments International is forecast to grow earnings and revenue by 93.1% and 14.4% per annum respectively. EPS is expected to grow by 94.3% per annum. Return on equity is forecast to be 7% in 3 years.

Key information

93.1%

Earnings growth rate

94.3%

EPS growth rate

Pharmaceuticals earnings growth49.4%
Revenue growth rate14.4%
Future return on equity7.0%
Analyst coverage

Low

Last updated25 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

CHIA:MVP - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2027554471
6/30/2026480571
6/30/202541-4131
6/30/202433-41-14-11N/A
3/31/202433-30-17-12N/A
12/31/202334-19-21-15N/A
9/30/202333-12-23-16N/A
6/30/202332-6-24-16N/A
3/31/202329-4-22-16N/A
12/31/202226-2-20-15N/A
9/30/202224-7-18-13N/A
6/30/202222-12-16-11N/A
3/31/202222-16-17-10N/A
12/31/202122-19-17-10N/A
9/30/202124-16-16-9N/A
6/30/202125-13-15-9N/A
3/31/202125-7-14-8N/A
12/31/202024-1-13-6N/A
9/30/2020230-11-3N/A
6/30/2020230-90N/A
3/31/2020221-81N/A
12/31/2019221-81N/A
9/30/2019221211N/A
6/30/20192111121N/A
3/31/20192011222N/A
12/31/20181901223N/A
9/30/2018180212N/A
6/30/2018170-92N/A
3/31/2018181N/A2N/A
12/31/2017182N/A3N/A
9/30/2017182N/A3N/A
6/30/2017182N/A4N/A
3/31/2017182N/A4N/A
12/31/2016182N/A4N/A
9/30/2016172N/A8N/A
6/30/2016152N/A12N/A
3/31/2016141N/A12N/A
12/31/2015121N/A13N/A
9/30/2015121N/A8N/A
6/30/2015122N/A3N/A
3/31/2015111N/A3N/A
12/31/2014101N/A3N/A
9/30/2014101N/A2N/A
6/30/201491N/A1N/A
3/31/2014101N/A1N/A
12/31/2013101N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MVP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: MVP is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MVP is expected to become profitable in the next 3 years.

Revenue vs Market: MVP's revenue (14.4% per year) is forecast to grow faster than the Australian market (5.8% per year).

High Growth Revenue: MVP's revenue (14.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MVP's Return on Equity is forecast to be low in 3 years time (7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y